Have a personal or library account? Click to login
Pre‑exposure Prophylaxis Awareness and Endorsement among Adolescents and Young Adults in Tanzania: Insights from the 2022 Demographic and Health Survey Cover

Pre‑exposure Prophylaxis Awareness and Endorsement among Adolescents and Young Adults in Tanzania: Insights from the 2022 Demographic and Health Survey

Open Access
|Jan 2025

References

  1. UNAIDS. Global HIV & AIDS statistics—fact sheet. Accessed July 18, 2024. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.
  2. Tanzania HIV and Impact Survey. THIS 2022–2023. Accessed June 3, 2024. https://phia.icap.columbia.edu/wp-content/uploads/2023/12/THIS-SS_5DEC2023.pdf.
  3. UNAIDS. End inequalities. End AIDS: Global AIDS Strategy 2021–2026. Accessed July 18, 2024. https://www.unaids.org/sites/default/files/media_asset/global-AIDS-strategy-2021-2026-summary_en.pdf.
  4. Ministry of Health. Tanzania National Guidelines for the Management of HIV and AIDS, 7th edition. Accessed August 13, 2024. https://hivpreventioncoalition.unaids.org/en/resources/tanzania-national-guidelines-management-hiv-and-aids-7th-edition.
  5. National AIDS Control Programme. Prevention of new HIV infection. Accessed August 13, 2024. https://nacp.go.tz/prevention-of-new-hiv-infection/.
  6. Tanzania HIV Impact Survey. THIS 2016–2017. Accessed June 3, 2024. https://phia.icap.columbia.edu/wp-content/uploads/2019/06/FINAL_THIS-2016-2017_Final-Report__06.21.19_for-web_TS.pdf.
  7. Tanzania HIV Impact Survey. Accessed July 13, 2024. https://www.nbs.go.tz/nbs/takwimu/THIS2022-2023/THIS2022-2023_Summary_Sheet.pdf.
  8. Jourdain H, de Gage SB, Desplas D, Dray‑Spira R. Real‑world effectiveness of pre‑exposure prophylaxis in men at high risk of HIV infection in France: A nested case‑control study. Lancet Public Health. June 2022;7(6):e529e536. doi:10.1016/s2468-2667(22)00106-2.
  9. Young LE, Schumm P, Alon L, et al. PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre‑exposure prophylaxis for HIV prevention among young Black men who have sex with men. Clin Trials. February 2018;15(1):4452. doi:10.1177/1740774517730012.
  10. Kibengo FM, Ruzagira E, Katende D, et al. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre‑exposure prophylaxis (PrEP) among HIV‑uninfected Ugandan volunteers living in HIV‑serodiscordant relationships: A randomized, clinical trial. PLoS One. 2013;8(9):e74314. doi:10.1371/journal.pone.0074314.
  11. Mrisho A, Rutatinisibwa H, Msalale G, et al. Reasons influencing PrEP continuity among key and priority populations in Tabora region, Tanzania: A cross‑sectional study. Student’s J Health Res Afr. 2022;3(12):11.
  12. Martin VO, Tesha NA, Sunguya BF. Uptake of oral HIV pre‑exposure prophylaxis (PrEP) and associated factors among female sex workers in Tanga, Tanzania. Viruses. October 20, 2023;15(10):2125. doi:10.3390/v15102125.
  13. Faini D, Munseri P, Sandstrom E, Hanson C, Bakari M. Awareness, willingness and use of HIV pre‑exposure prophylaxis among female sex workers living in Dar‑es‑Salaam, Tanzania. AIDS Behav. January 2023;27(1):335343. doi:10.1007/s10461-022-03769-4.
  14. Hwenda L. Delivering the promise of a miracle formula—Lenacapavir—to prevent HIV in Africa I Medicines for Africa. Published August 8, 2024. Accessed August 13, 2024. https://www.linkedin.com/pulse/delivering-promise-miracle-formula-lenacapavir-vtece/.
  15. Ramadhani HO, Crowell TA, Nowak RG, et al. Determinants of preexposure prophylaxis cascade among sexual and gender minorities in Nigeria. Sex Transm Dis. September 1, 2023;50(9):559566. doi:10.1097/olq.0000000000001841.
  16. Rodriguez A, Horvath KJ, Dowshen N, et al. Awareness and utilization of pre‑exposure prophylaxis and HIV prevention services among transgender and non‑binary adolescent and young adults. Front Reprod Health. 2023;5:1150370. doi:10.3389/frph.2023.1150370.
  17. Kampamba M, Nelumbu NN, Hikaambo CN, et al. Awareness and willingness to use pre‑exposure prophylaxis among the University of Zambia students: A cross‑sectional study. Health Sci Rep. September 2024;7(9):e70060. doi:10.1002/hsr2.70060.
  18. ICF. Demographic and Health Survey Interviewer’s Manual. Rockville, Maryland, U.S.A.: ICF. Accessed December 11, 2024. https://dhsprogram.com/pubs/pdf/DHSM1/DHS8-Interviewer’s-Manual-EN-07Jan2022.pdf.
  19. Ministry of Health Tanzania. Demographic and Health Survey and Malaria Indicator Survey (TDHS‑MIS). Accessed February 15, 2024. https://dhsprogram.com/.
  20. Taber KS. The use of Cronbach’s alpha when developing and reporting research instruments in science education. Res Sci Educ. 2018;48:12731296. 10.1007/s11165-016-9602-2.
  21. Kabaghe AN, Singano V, Payne D, et al. Awareness of and willingness to use oral pre‑exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: Results from the 2020 Malawi population‑based HIV impact assessment. BMC Infect Dis. October 20, 2023;23(1):712. doi:10.1186/s12879-023-08683-1.
  22. Ajayi AI, Mudefi E, Yusuf MS, Adeniyi OV, Rala N, Goon DT. Low awareness and use of pre‑exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings. Medicine (Baltimore). October 2019;98(43):e17716. doi:10.1097/md.0000000000017716.
  23. Currie DW, West CA, Patel HK, et al. Risk factors for recent HIV infections among adults in 14 countries in Africa identified by population‑based HIV impact assessment surveys, 2015–2019. Emerg Infect Dis. November 2023;29(11):23252334. doi:10.3201/eid2911.230703.
  24. Ferrand R, Lowe S, Whande B, et al. Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ. June 2010;88(6):428434. doi:10.2471/blt.09.066126.
  25. Centers for Disease Control and Prevention (CDC). HIV in the USA. Accessed June 3, 2024. https://www.cdc.gov/hiv/data-research/facts-stats/age.html?CDC_AAref_Val=https://www.cdc.gov/hiv/group/age/index.html.
  26. USAID. Tanzania HIV/AIDS. Accessed June 3, 2024. https://www.usaid.gov/sites/default/files/2023-06/HIV-AIDS%20TANZANIA%20Factsheet.pdf.
  27. O’Rourke S, Hartmann M, Myers L, et al. The PrEP journey: Understanding how internal drivers and external circumstances impact the PrEP trajectory of adolescent girls and young women in Cape Town, South Africa. AIDS Behav. July 2021;25(7):21542165. doi:10.1007/s10461-020-03145-0.
  28. Celum CL, Delany‑Moretlwe S, Baeten JM, et al. HIV pre‑exposure prophylaxis for adolescent girls and young women in Africa: From efficacy trials to delivery. J Int AIDS Soc. July 2019;22(Suppl 4):e25298. doi:10.1002/jia2.25298.
  29. Walters SM, Frank D, Van Ham B, et al. PrEP care continuum engagement among persons who inject drugs: Rural and urban differences in stigma and social infrastructure. AIDS Behav. April 2022;26(4):13081320. doi:10.1007/s10461-021-03488-2.
  30. Owens C. HIV pre‑exposure prophylaxis awareness, practices, and comfort among urban and rural family medicine physicians. J Rural Health. March 2023;39(2):469476. doi:10.1111/jrh.12723.
DOI: https://doi.org/10.5334/aogh.4589 | Journal eISSN: 2214-9996
Language: English
Submitted on: Oct 18, 2024
|
Accepted on: Dec 19, 2024
|
Published on: Jan 24, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Alpha Johnson Kapola, Rahma Musoke, Glenda Marie Manayon, Hassan Fredrick Fussi, Hafidha Mhando Bakari, Haji Mbwana Ally, Swalehe Mustafa Salim, Zuhura Mbwana Ally, Lynn Moshi, Mariam Salim Mbwana, Habib Omari Ramadhani, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.